HSPA1A and inflammatory bowel disease: Therefore, our data unequivocally unravel a novel mechanism whereby IPA maintains intestinal mucosal homeostasis and restrains mucosal inflammation through promoting Hsp70-mediated Th1/Th17 cell apoptosis, and provide a novel therapeutic avenue for the treatment of IBD.